Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
23/02 | Clearmind Medicine Says Israel Approves Start of Clinical Trial of CMND-100 for Alcohol Use Disorder | MT |
05/02 | Clearmind Medicine Receives Patent Approval in China | MT |
Sales 2015 | - | Sales 2016 | - | Capitalization | 1.19Cr 100Cr |
---|---|---|---|---|---|
Net income 2015 | - 0 | Net income 2016 | - 0 | EV / Sales 2015 * | - |
Net cash position 2015 * | - 0 | Net cash position 2016 * | - 0 | EV / Sales 2016 * | - |
P/E ratio 2015 * |
-
| P/E ratio 2016 * |
-
| Employees | - |
Yield 2015 * |
-
| Yield 2016 * |
-
| Free-Float | 95.71% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 1.19Cr | |
+43.76% | 1,29100Cr | |
-3.21% | 2.89TCr | |
-14.93% | 824.9Cr | |
-24.47% | 201.22Cr | |
-25.92% | 137.81Cr | |
+37.04% | 101.08Cr | |
-7.37% | 58Cr | |
+17.14% | 42Cr | |
-16.50% | 40Cr |
- Stock Market
- Equities
- CMND Stock